-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JsyREiAka/1sh1ciP4ffJ9xP8qdknAeeOYsIafzb5VjPu8HtRxMx4WYvIOg8V6rT Yfy5O1nXuFQ5veu6w1Oz7Q== 0000851909-07-000013.txt : 20070216 0000851909-07-000013.hdr.sgml : 20070216 20070216125421 ACCESSION NUMBER: 0000851909-07-000013 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070216 DATE AS OF CHANGE: 20070216 GROUP MEMBERS: ISRAEL A. ENGLANDER GROUP MEMBERS: MILLENCO, L.L.C. GROUP MEMBERS: MILLENNIUM MANAGEMENT, L.L.C. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ADVANCIS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001161924 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522208264 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79326 FILM NUMBER: 07630294 BUSINESS ADDRESS: STREET 1: 20425 SENECA MEADOWS PARKWAY CITY: GERMANTOWN STATE: MD ZIP: 20878 BUSINESS PHONE: (301) 944-6600 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MILLENNIUM PARTNERS, L.P. CENTRAL INDEX KEY: 0000851909 IRS NUMBER: 133521699 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: C/O MILLENNIUM MANAGEMENT, L.L.C. STREET 2: 666 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10103 BUSINESS PHONE: 2128414000 MAIL ADDRESS: STREET 1: C/O MILLENNIUM MANAGEMENT, L.L.C. STREET 2: 666 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10103 FORMER COMPANY: FORMER CONFORMED NAME: MILLENNIUM PARTNERS L P DATE OF NAME CHANGE: 20000628 SC 13D/A 1 avnc_13d-a1.htm AVNC SCHEDULE 13D AMENDMENT NO. 1 SCHEDULE 13D

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
Under the Securities Exchange Act of 1934

(Amendment No. 1)*


       
                             Advancis Pharmaceutical Corporation                             
(Name of Issuer)

                             Common Stock, Par Value $0.01 Per Share                            
(Title of Class of Securities)


                                                         00764L109                                                           
(CUSIP Number)

Simon M. Lorne, Esq.
Millennium Management, L.L.C.
666 Fifth Avenue, 8th Floor
New York, New York 10103
                                                     (212) 841-4100                                                       
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)

                                                    February 14, 2006                                                   
(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because § 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g) check the following box o .

 


SCHEDULE 13D

CUSIP No. 00764L109
1
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

Millennium Partners, L.P.
13-3521699
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)   o
(b)   þ
3
SEC USE ONLY
4
SOURCE OF FUNDS (See Instructions)

WC, OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

 
þ
6
CITIZENSHIP OR PLACE OF ORGANIZATION

Cayman Islands
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER

2,100,000
8
SHARED VOTING POWER

-0-
 
9
SOLE DISPOSITIVE POWER

2,100,000
 
10
SHARED DISPOSITIVE POWER

-0-
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,731,034
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) 

 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

7.5%
14
TYPE OF REPORTING PERSON

PN

SCHEDULE 13D

CUSIP No. 00764L109
1
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

Millenco, L.L.C.
13-3532932
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)   o
(b)   þ
3
SEC USE ONLY
4
SOURCE OF FUNDS

WC, OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

 
þ
6
CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER

631,034
8
SHARED VOTING POWER

-0-
 
9
SOLE DISPOSITIVE POWER

631,034
 
10
SHARED DISPOSITIVE POWER

-0- 

11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,731,034

12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

7.5%

14
TYPE OF REPORTING PERSON

OO, BD

SCHEDULE 13D

CUSIP No. 00764L109
1
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

Millennium Management, L.L.C.
13-3804139
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)   o
(b)   þ
3
SEC USE ONLY
4

SOURCE OF FUNDS

WC, OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

þ

6
CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER

2,731,034

8
SHARED VOTING POWER

-0- 
9
SOLE DISPOSITIVE POWER
 
2,731,034
10
SHARED DISPOSITIVE POWER

-0- 

11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,731,034
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
7.5%
14
TYPE OF REPORTING PERSON
 
OO

SCHEDULE 13D

CUSIP No. 00764L109
1
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

Israel A. Englander
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)   o
(b)   þ
3
SEC USE ONLY
4

SOURCE OF FUNDS

WC, OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

þ

6
CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER

2,731,034

8
SHARED VOTING POWER

-0- 
9
SOLE DISPOSITIVE POWER
 
2,731,034 
10
SHARED DISPOSITIVE POWER

-0- 

11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,731,034
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
7.5%
14
TYPE OF REPORTING PERSON
 
IN

Explanatory Note

Introduction

    This Amendment No. 1 ("Amendment No. 1") amends the Schedule 13D filed on December 22, 2006 (the "Schedule 13D") by the reporting persons, relating to their beneficial ownership of Common Stock (defined below) of Advancis Pharmaceutical Corporation (the "Issuer").

    This Amendment No. 1 (i) amends and restates Item 2, Item 3 and Item 5 and (ii) reflects a material change since the filing of the Schedule 13D in the number of shares beneficially owned by Millenco, L.L.C. (and that may be deemed to be beneficially owned by the other reporting persons) and the percentage ownership of the Issuer’s Common Stock represented by Millennium Partners, L.P.’s and Millenco, L.L.C.’s ownership of such shares. Except for the above-referenced amendments, Amendment No. 1 does not modify any of the information previously reported on the Schedule 13D.

Item 1.          Security and Issuer.

    The name of the issuer is Advancis Pharmaceutical Corporation, a Delaware corporation. The address of the Issuer’s offices is 20425 Seneca Meadows Parkway, Germantown, Maryland 20876. This Schedule 13D relates to the Issuer’s common stock, par value $0.01 per share (the "Common Stock").

Item 2.          Identity and Background.

    (a)-(c), (f). This statement is being filed by Millennium Partners, L.P., a Cayman Islands exempted limited partnership ("Millennium Partners") and Millenco, L.L.C., a Delaware limited liability company, formerly known as Millenco, L.P., a Delaware limited partnership ("Millenco"). Millenco is a broker-dealer and a member of the American Stock Exchange and the NASDAQ. Millennium Management, L.L.C., a Delaware limited liability company ("Millennium Management"), is the managing partner of Millennium Partners and the manager of Millenco, and consequently may be deemed to have voting control and investment discretion over securities owned by Millennium Partners and by Millenco. Israel A. Englander ("Mr. Englander") is the managing member of Millennium Management. As a result, Mr. Englander may be deemed to be the beneficial owner of any shares deemed to be beneficially owned by Millennium Management. The foregoing should not be const rued in and of itself as an admission by Millennium Management or Mr. Englander as to beneficial ownership of the shares owned by Millennium Partners or by Millenco.

    The business address for Millennium Partners, Millenco, Millennium Management and Mr. Englander is c/o Millennium Management, L.L.C., 666 Fifth Avenue, New York, New York 10103. Mr. Englander is a United States citizen.

    Note: Integrated Holding Group, L.P., a Delaware limited partnership ("Integrated Holding Group"), is a non-managing member of Millenco. As a non-managing member, Integrated Holding Group has no investment or voting control over Millenco or its securities positions.

    (d).     During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

    (e).     On December 1, 2005, Millennium Management and Mr. Englander, together with Millennium Partners and certain related persons and entities, entered into settlements with the Securities and Exchange Commission (“SEC”) and the Attorney General of the State of New York (the “NYAG”) relating to allegations that Millennium Partners had engaged in a pattern of deceptive “market timing” of mutual fund shares in years prior to 2004 and, in the case of the settlement with the NYAG only, had failed to take adequate steps to prevent a trader from engaging in mutual fund “late trading” in violation of firm policy. The parties neither admitted nor denied the allegations or findings (except as to jurisdiction) but consented to the entry of findings. The SEC proceedings are In the Matter of Millennium Partners, L.P., et al. Securities Act Release No. 8639 (December 1, 2005) , available at www.sec.gov. Contemporaneously, the NYAG issued an Assurance of Discontinuance relating to the claims and findings of that office.

    Neither the Reporting Persons nor any other party admitted or denied any of the allegations or findings in these matters. The remedies included disgorgement by the entities of approximately $148 million of mutual fund trading profits, civil penalties aggregating approximately $32.15 million (with approximately $30 million being paid by Mr. Englander), an administrative order to cease and desist from violations of the antifraud provisions of the Securities Act and the Securities Exchange Act, and prophylactic relief.

Item 3.          Source and Amount of Funds or Other Consideration.

    Pursuant to a Subscription Agreement dated as of December 11, 2006 between the Issuer and Millennium Partners, Millennium Partners expended $6,300,000 in a private placement transaction to acquire 2,100,000 shares of Common Stock. The amount of funds used to purchase the remaining 631,034 shares held by Millenco in transactions giving rise to this Schedule 13D was approximately $1,478,600, calculated on an average cost basis (excluding brokerage commissions) by account. Millennium Partners and Millenco effect purchases of securities primarily through margin accounts maintained for them with prime brokers, which may extend margin credit to them as and when required to open or carry positions in the margin accounts, subject to applicable Federal margin regulations, stock exchange rules and the prime broke r's credit policies. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the accounts.

Item 4.          Purpose of Transaction.

    The Reporting Persons are engaged in the investment business. In pursuing this business, the Reporting Persons analyze the operations, capital structure and markets of companies, including the Issuer, on a continuous basis through analysis of documentation and discussions with knowledgeable industry and market observers and with representatives of such companies (often at the invitation of management). From time to time, one or more of the Reporting Persons may hold discussions with third parties or with management of such companies in which the Reporting Persons may suggest or take a position with respect to potential changes in the operations, management or capital structure of such companies as a means of enhancing shareholder value. Such suggestions or positions may relate to one or more of the transactions specified in clauses (a) through (j) of Item 4 of Schedule 13D of the Exchange Act, including, without limitation, such matters as disposing of or selling all or a portion of the company or acquiring another company or business, changing operating or marketing strategies, adopting or not adopting certain types of anti-takeover measures and restructuring the issuer's capitalization or dividend policy.

    The Reporting Persons employ the services of a number of portfolio managers, each of whom independently employs a separate and distinct trading strategy. A portion of the securities of the Issuer held by the Reporting Persons are held in accounts of the Reporting Persons managed by portfolio managers who engage in event-, risk- or merger-arbitrage or fundamental strategies.

Except as set forth above, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the actions required to be described in Item 4 of Schedule 13D. Each of the Reporting Persons may, at any time, review or reconsider its position with respect to the Issuer and formulate plans or proposals with respect to any of such matters, but has no present intention of doing so.

Item 5.          Interest in Securities of the Issuer.

    (a)     As of the date of this filing, (i) Millennium Partners is the beneficial owner of 2,100,000 shares of Common Stock and (ii) Millenco is the beneficial owner of 631,034 shares of Common Stock.

    Millennium Management, as the managing partner of Millennium Partners and the manager of Millenco, may also be deemed to beneficially own the above-described shares of Common Stock beneficially owned by Millennium Partners and Millenco, respectively.

    Mr. Englander, as the managing member of Millennium Management, may also be deemed to beneficially own the above-described shares of Common Stock beneficially owned by Millennium Partners and Millenco, respectively.

    The foregoing should not be construed in and of itself as an admission by Millennium Management or Mr. Englander as to beneficial ownership of the shares held by Millennium Partners and Millenco.

    Accordingly, as of the date of this filing, Mr. Englander and Millennium Management may be deemed to be the beneficial owner of 2,731,034 shares of Common Stock, which represents in the aggregate approximately 7.5% of the outstanding shares of Common Stock. The calculation of the foregoing percentage is on the basis of (i) 30,380,882 shares of Common Stock outstanding, as reported by the Issuer on Exhibit 10.2 to Form 8-K (the Securities Purchase Agreement dated as of December 11, 2006) filed as of December 13, 2006 (the “Form 8-K”), plus (ii) 6,000,000 shares of Common Stock issued on December 14, 2006 as reported in the Form 8-K, for a total of 36,380,882 shares of Common Stock outstanding as of December 14, 2006.

    (b)     Millennium Partners may be deemed to hold the sole power to vote and to dispose of the 2,100,000 shares of Common Stock described in (a) above. Millenco may be deemed to hold the sole power to vote and to dispose of the 631,034 shares of Common Stock described in (a) above. Mr. Englander and Millennium Management may be deemed to hold the sole power to vote and to dispose of the 2,731,034 shares of Common Stock described in (a) above. The foregoing should not be construed in and of itself as an admission by Mr. Englander or Millennium Management as to beneficial ownership of the shares held by Millennium Partners and Millenco.

    (c)     Transactions in Common Stock during the past 60 days: Schedule A annexed hereto lists all transactions in the Common Stock during the past 60 days by the Reporting Persons. All transactions in the Common Stock were effected in the open market.

    (d)     No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of, dividends from, or proceeds from the sale of, the shares of Common Stock reported in this Statement.

Item 6.          Contracts, Arrangements, Understandings or Relationships with Respect  to Securities of the Issuer.

     Millenco maintains an open short position of 33,847 shares of Common Stock, which position is not netted against the data provided herein as to the number of shares beneficially owned by the Reporting Persons.

     In connection with arrangements with its prime brokers, such prime brokers are permitted to lend securities in Millenco’s and Millennium Partners’ accounts (as the case may be) to the extent permitted by debit balances in such account. Millenco and Millennium Partners (as the case may be) generally will not have any knowledge of the specific loans made by such prime brokers. In addition, in the ordinary course of business, Millenco and/or Millennium Partners, as applicable (or its prime brokers), may borrow securities to satisfy delivery obligations arising from short sales and may lend securities to third parties and such loans generally may be recalled upon demand..

      There are no other contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer.

Item 7.          Material to Be Filed as Exhibits.

     Exhibit I:    Joint Filing Agreement, dated as of February 15, 2007, by and among Millennium Partners, L.P., Millenco, L.L.C., Millennium Management, L.L.C. and Israel A. Englander.


SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 15, 2007

MILLENNIUM PARTNERS, L.P.

By: Millennium Management, L.L.C.
       its managing partner

By:  /s/ Terry Feeney                                          
     Name: Terry Feeney
     Title:   Chief Operating Officer

 

MILLENCO, L.L.C.

By: Millennium Management, L.L.C.
       as manager

By:  /s/ Terry Feeney                                          
     Name: Terry Feeney
     Title:   Chief Operating Officer

 

MILLENNIUM MANAGEMENT, L.L.C.

By:  /s/ Terry Feeney                                          
     Name: Terry Feeney
     Title:   Chief Operating Officer

 

/s/ Israel A. Englander by David Nolan               
pursuant to Power of Attorney filed with         
the SEC on June 6, 2005                                   
Israel A. Englander

EXHIBIT I

JOINT FILING AGREEMENT

This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.01 per share, of Advancis Pharmaceutical Corporation, a Delaware corporation, is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

Dated: February 15, 2007

MILLENNIUM PARTNERS, L.P.

By: Millennium Management, L.L.C.
       its managing partner

By:  /s/ Terry Feeney                                          
     Name: Terry Feeney
     Title:   Chief Operating Officer

 

MILLENCO, L.L.C.

By: Millennium Management, L.L.C.
       as manager

By:  /s/ Terry Feeney                                          
     Name: Terry Feeney
     Title:   Chief Operating Officer

 

MILLENNIUM MANAGEMENT, L.L.C.

By:  /s/ Terry Feeney                                          
     Name: Terry Feeney
     Title:   Chief Operating Officer

 

/s/ Israel A. Englander by David Nolan               
pursuant to Power of Attorney filed with         
the SEC on June 6, 2005                                   
Israel A. Englander

Schedule A

Transactions in the Issuer’s Common Stock During the Past 60 Days:

Date of Transaction Quantity Purchased
(Sold)
Price Per Share
$
12/18/2006 (500) 3.7466
12/19/2006 (200) 3.6066
12/20/2006 (400) 3.7766
12/20/2006 (200) 3.7966
12/21/2006 (100) 3.5666
12/21/2006 (100) 3.6266
12/22/2006 100 3.56
12/22/2006 100 3.56
12/22/2006 100 3.56
12/22/2006 100 3.56
12/26/2006 100 3.57
12/26/2006 100 3.58
12/26/2006 90 3.48
12/26/2006 90 3.56
12/26/2006 100 3.48
12/26/2006 100 3.51
12/26/2006 100 3.55
12/26/2006 100 3.56
12/26/2006 100 3.57
12/26/2006 100 3.58
12/26/2006 100 3.58
12/26/2006 100 3.58
12/26/2006 100 3.58
12/26/2006 100 3.61
12/26/2006 100 3.62
12/26/2006 100 3.62
12/26/2006 100 3.62
12/26/2006 100 3.62
12/26/2006 100 3.55
12/27/2006 100 3.66
12/27/2006 100 3.67
12/27/2006 100 3.69
12/27/2006 100 3.71
12/27/2006 100 3.71
12/27/2006 100 3.72
12/27/2006 100 3.74
12/27/2006 100 3.75
12/27/2006 100 3.75
12/27/2006 100 3.75
12/27/2006 100 3.75
12/27/2006 100 3.75
12/27/2006 100 3.75
12/27/2006 100 3.76
12/27/2006 100 3.77
12/27/2006 100 3.78
12/27/2006 100 3.78
12/27/2006 100 3.79
12/27/2006 100 3.79
12/27/2006 100 3.79
12/27/2006 100 3.79
12/27/2006 100 3.79
12/27/2006 100 3.79
12/27/2006 100 3.82
12/27/2006 100 3.83
12/27/2006 100 3.83
12/27/2006 200 3.83
12/27/2006 300 3.76
12/27/2006 100 3.74
12/27/2006 100 3.79
12/28/2006 100 4.02
12/28/2006 80 3.93
12/28/2006 100 3.92
12/28/2006 100 3.92
12/28/2006 100 3.98
12/28/2006 100 3.99
12/28/2006 100 3.99
12/28/2006 100 4
12/28/2006 100 4
12/28/2006 100 4
12/28/2006 100 4
12/28/2006 100 4.02
12/28/2006 100 4.02
12/28/2006 100 4.02
12/28/2006 100 4.02
12/28/2006 100 4.02
12/28/2006 100 4.03
12/28/2006 100 4.03
12/28/2006 100 4.03
12/28/2006 100 4.03
12/28/2006 100 4.05
12/28/2006 100 4.05
12/28/2006 200 4.04
12/28/2006 200 4.04
12/28/2006 200 4.04
12/28/2006 100 4
12/28/2006 (300) 3.9266
12/28/2006 (200) 3.9566
12/29/2006 (100) 3.88
12/29/2006 (100) 3.88
12/29/2006 (100) 3.88
12/29/2006 (100) 3.88
12/29/2006 (100) 3.88
12/29/2006 (100) 3.88
12/29/2006 (100) 3.89
12/29/2006 (100) 3.89
12/29/2006 (100) 3.89
12/29/2006 (100) 3.89
12/29/2006 (100) 3.89
12/29/2006 (100) 3.89
12/29/2006 (100) 3.91
12/29/2006 (100) 3.91
12/29/2006 (100) 3.91
12/29/2006 (100) 3.91
12/29/2006 (100) 3.91
12/29/2006 (100) 3.91
12/29/2006 (100) 3.91
12/29/2006 (100) 3.91
12/29/2006 (100) 3.95
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.92
12/29/2006 100 3.94
12/29/2006 100 3.94
12/29/2006 100 3.95
12/29/2006 100 3.97
12/29/2006 100 3.88
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.9
12/29/2006 100 3.91
12/29/2006 100 3.93
12/29/2006 100 3.98
12/29/2006 (100) 3.8966
12/29/2006 (100) 3.9967
1/3/2007 100 3.69
1/3/2007 100 3.69
1/3/2007 100 3.69
1/3/2007 100 3.69
1/3/2007 100 3.69
1/3/2007 100 3.68
1/3/2007 100 3.68
1/3/2007 100 3.69
1/3/2007 100 3.82
1/3/2007 100 3.6
1/3/2007 100 3.6
1/3/2007 100 3.66
1/3/2007 100 3.66
1/3/2007 100 3.66
1/3/2007 100 3.66
1/3/2007 100 3.66
1/3/2007 100 3.66
1/3/2007 100 3.67
1/3/2007 100 3.67
1/3/2007 100 3.67
1/3/2007 100 3.68
1/3/2007 100 3.68
1/3/2007 100 3.68
1/3/2007 100 3.68
1/3/2007 100 3.68
1/3/2007 100 3.75
1/3/2007 100 3.77
1/3/2007 100 3.77
1/3/2007 100 3.8
1/3/2007 100 3.8
1/3/2007 100 3.82
1/3/2007 100 3.84
1/3/2007 200 3.69
1/3/2007 100 3.65
1/3/2007 100 3.66
1/3/2007 100 3.71
1/4/2007 100 3.63
1/4/2007 100 3.63
1/4/2007 100 3.63
1/4/2007 100 3.63
1/4/2007 100 3.63
1/4/2007 100 3.63
1/4/2007 100 3.63
1/4/2007 100 3.63
1/4/2007 100 3.64
1/4/2007 100 3.64
1/4/2007 100 3.64
1/4/2007 23 3.6134
1/4/2007 800 3.6313
1/4/2007 50 3.62
1/4/2007 100 3.61
1/4/2007 100 3.61
1/4/2007 100 3.62
1/4/2007 100 3.62
1/4/2007 100 3.62
1/4/2007 100 3.62
1/4/2007 100 3.63
1/4/2007 100 3.64
1/4/2007 100 3.64
1/4/2007 100 3.64
1/4/2007 100 3.62
1/4/2007 100 3.62
1/5/2007 100 3.56
1/5/2007 100 3.62
1/5/2007 200 3.5434
1/5/2007 100 3.51
1/5/2007 100 3.49
1/5/2007 100 3.49
1/5/2007 100 3.49
1/5/2007 100 3.49
1/5/2007 100 3.5
1/5/2007 100 3.5
1/5/2007 100 3.5
1/5/2007 100 3.51
1/5/2007 100 3.51
1/5/2007 100 3.51
1/5/2007 100 3.51
1/5/2007 100 3.52
1/5/2007 100 3.52
1/5/2007 100 3.53
1/5/2007 100 3.54
1/5/2007 100 3.54
1/5/2007 100 3.47
1/5/2007 100 3.48
1/5/2007 100 3.49
1/5/2007 100 3.49
1/5/2007 100 3.54
1/5/2007 100 3.55
1/5/2007 100 3.56
1/8/2007 100 3.47
1/8/2007 600 3.47
1/8/2007 100 3.47
1/8/2007 100 3.47
1/8/2007 100 3.48
1/8/2007 100 3.48
1/8/2007 100 3.48
1/8/2007 100 3.48
1/8/2007 100 3.48
1/8/2007 100 3.49
1/8/2007 100 3.49
1/8/2007 100 3.49
1/8/2007 100 3.49
1/8/2007 100 3.49
1/8/2007 100 3.5
1/8/2007 200 3.48
1/8/2007 100 3.48
1/9/2007 100 3.4034
1/9/2007 100 3.37
1/9/2007 100 3.42
1/9/2007 (700) 3.37
1/9/2007 50 3.36
1/9/2007 99 3.35
1/9/2007 100 3.26
1/9/2007 100 3.26
1/9/2007 100 3.27
1/9/2007 100 3.29
1/9/2007 100 3.3
1/9/2007 100 3.3
1/9/2007 100 3.3
1/9/2007 100 3.34
1/9/2007 100 3.34
1/9/2007 100 3.34
1/9/2007 100 3.35
1/9/2007 100 3.36
1/9/2007 100 3.36
1/9/2007 100 3.36
1/9/2007 100 3.36
1/9/2007 100 3.36
1/9/2007 100 3.36
1/9/2007 100 3.37
1/9/2007 100 3.37
1/9/2007 100 3.4
1/9/2007 100 3.4
1/9/2007 100 3.4
1/9/2007 100 3.41
1/9/2007 100 3.41
1/9/2007 100 3.41
1/9/2007 100 3.41
1/9/2007 200 3.28
1/10/2007 100 3.35
1/10/2007 17 3.36
1/10/2007 66 3.38
1/10/2007 100 3.34
1/10/2007 100 3.34
1/10/2007 100 3.35
1/10/2007 100 3.36
1/10/2007 100 3.36
1/10/2007 100 3.36
1/10/2007 100 3.37
1/10/2007 100 3.37
1/10/2007 100 3.38
1/10/2007 100 3.38
1/10/2007 100 3.38
1/10/2007 100 3.38
1/10/2007 100 3.38
1/10/2007 12 3.35
1/10/2007 100 3.35
1/10/2007 100 3.38
1/11/2007 100 3.3934
1/11/2007 100 3.34
1/11/2007 20 3.3
1/11/2007 100 3.28
1/11/2007 100 3.29
1/11/2007 100 3.34
1/11/2007 100 3.35
1/11/2007 100 3.38
1/11/2007 100 3.4
1/11/2007 400 3.29
1/11/2007 24 3.29
1/11/2007 100 3.29
1/11/2007 100 3.29
1/12/2007 5 3.04
1/12/2007 5 3.05
1/12/2007 95 3.05
1/12/2007 100 3.04
1/12/2007 100 3.04
1/12/2007 100 3.04
1/12/2007 100 3.04
1/12/2007 100 3.04
1/12/2007 100 3.04
1/12/2007 100 3.05
1/12/2007 100 3.05
1/12/2007 100 3.05
1/12/2007 100 3.05
1/12/2007 100 3.05
1/12/2007 100 3.05
1/12/2007 100 3.05
1/12/2007 100 3.06
1/12/2007 100 3.06
1/12/2007 100 3.06
1/12/2007 100 3.06
1/12/2007 100 3.07
1/12/2007 100 3.07
1/12/2007 100 3.07
1/12/2007 100 3.07
1/12/2007 100 3.07
1/12/2007 100 3.07
1/12/2007 100 3.07
1/12/2007 100 3.07
1/12/2007 (100) 3.05
1/12/2007 100 3.0534
1/12/2007 400 3.12
1/12/2007 400 3.12
1/12/2007 100 3.1
1/12/2007 100 3.1027
1/12/2007 100 3.04
1/12/2007 100 3.04
1/12/2007 100 3.04
1/12/2007 100 3.04
1/12/2007 100 3.04
1/12/2007 100 3.05
1/12/2007 100 3.05
1/12/2007 100 3.06
1/12/2007 100 3.06
1/12/2007 100 3.06
1/12/2007 100 3.07
1/12/2007 100 3.07
1/12/2007 100 3.07
1/12/2007 100 3.08
1/12/2007 100 3.1
1/12/2007 100 3.1
1/12/2007 100 3.1
1/12/2007 100 3.1
1/12/2007 100 3.1
1/12/2007 100 3.1
1/12/2007 100 3.1
1/12/2007 100 3.1
1/12/2007 100 3.1
1/12/2007 100 3.1
1/12/2007 100 3.1
1/12/2007 100 3.1
1/12/2007 100 3.11
1/12/2007 100 3.12
1/12/2007 100 3.12
1/12/2007 100 3.12
1/12/2007 100 3.13
1/12/2007 100 3.14
1/12/2007 100 3.15
1/12/2007 100 3.15
1/12/2007 200 3.13
1/12/2007 100 3.04
1/12/2007 100 3.04
1/16/2007 95 3.09
1/16/2007 200 3.02
1/16/2007 400 3.02
1/16/2007 100 3.03
1/16/2007 100 3.04
1/16/2007 100 3.04
1/16/2007 100 3.04
1/16/2007 100 3.07
1/16/2007 100 3.07
1/16/2007 100 3.07
1/16/2007 100 3.1
1/16/2007 100 3.1
1/16/2007 100 3.1
1/16/2007 100 3.1
1/16/2007 100 3.11
1/16/2007 100 3.11
1/16/2007 100 3.11
1/16/2007 100 3.11
1/16/2007 100 3.02
1/16/2007 100 3.11
1/17/2007 100 2.95
1/17/2007 100 3.01
1/18/2007 100 2.85
1/18/2007 100 2.8334
1/18/2007 99 2.83
1/18/2007 100 2.83
1/18/2007 100 2.84
1/18/2007 100 2.84
1/18/2007 100 2.85
1/18/2007 100 2.85
1/18/2007 100 2.85
1/18/2007 100 2.85
1/18/2007 100 2.85
1/18/2007 100 2.85
1/18/2007 100 2.85
1/18/2007 100 2.85
1/18/2007 100 2.85
1/18/2007 100 2.85
1/18/2007 100 2.85
1/19/2007 100 2.86
1/19/2007 100 2.8
1/19/2007 100 2.81
1/19/2007 100 2.82
1/19/2007 100 2.82
1/19/2007 100 2.84
1/19/2007 100 2.84
1/19/2007 100 2.85
1/19/2007 100 2.87
1/19/2007 100 2.81
1/19/2007 200 2.81
1/22/2007 20 2.69
1/22/2007 80 2.7
1/22/2007 100 2.52
1/22/2007 100 2.55
1/22/2007 100 2.7134
1/22/2007 25 2.69
1/22/2007 100 2.52
1/22/2007 100 2.52
1/22/2007 100 2.53
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 100 2.55
1/22/2007 100 2.55
1/22/2007 100 2.56
1/22/2007 100 2.66
1/22/2007 100 2.67
1/22/2007 100 2.69
1/22/2007 100 2.71
1/22/2007 100 2.71
1/22/2007 100 2.72
1/22/2007 200 2.56
1/22/2007 100 2.54
1/22/2007 100 2.54
1/22/2007 200 2.54
1/22/2007 200 2.56
1/22/2007 300 2.54
1/22/2007 300 2.55
1/23/2007 100 2.44
1/23/2007 100 2.47
1/23/2007 1,200 2.4617
1/23/2007 100 2.42
1/23/2007 100 2.43
1/23/2007 100 2.43
1/23/2007 100 2.43
1/23/2007 100 2.44
1/23/2007 100 2.44
1/23/2007 100 2.44
1/23/2007 100 2.44
1/23/2007 100 2.44
1/23/2007 100 2.44
1/23/2007 100 2.46
1/23/2007 100 2.46
1/23/2007 100 2.46
1/23/2007 100 2.46
1/23/2007 100 2.46
1/23/2007 100 2.46
1/23/2007 100 2.46
1/23/2007 100 2.47
1/23/2007 100 2.47
1/23/2007 100 2.47
1/23/2007 100 2.48
1/23/2007 100 2.48
1/23/2007 100 2.48
1/23/2007 100 2.48
1/23/2007 100 2.48
1/23/2007 100 2.49
1/23/2007 100 2.49
1/23/2007 200 2.43
1/23/2007 100 2.45
1/23/2007 100 2.46
1/24/2007 (100) 2.78
1/24/2007 (100) 2.78
1/24/2007 (100) 2.78
1/24/2007 (100) 2.9
1/24/2007 (100) 2.6267
1/24/2007 (100) 2.7366
1/24/2007 (100) 2.7566
1/24/2007 100 2.77
1/24/2007 1,200 2.7404
1/24/2007 100 2.6
1/24/2007 100 2.62
1/24/2007 100 2.66
1/24/2007 100 2.7
1/24/2007 100 2.72
1/24/2007 100 2.74
1/24/2007 100 2.74
1/24/2007 100 2.76
1/24/2007 100 2.76
1/24/2007 100 2.76
1/24/2007 100 2.78
1/24/2007 100 2.79
1/24/2007 100 2.79
1/24/2007 100 2.8
1/24/2007 100 2.81
1/24/2007 100 2.81
1/24/2007 100 2.82
1/24/2007 100 2.82
1/24/2007 100 2.83
1/24/2007 100 2.89
1/24/2007 100 2.95
1/24/2007 100 2.74
1/24/2007 100 2.79
1/24/2007 200 2.79
1/25/2007 (100) 2.73
1/25/2007 (100) 2.6966
1/25/2007 (100) 2.7267
1/25/2007 100 2.59
1/26/2007 (100) 2.65
1/26/2007 (100) 2.66
1/26/2007 (100) 2.67
1/26/2007 (100) 2.67
1/26/2007 (100) 2.68
1/26/2007 (100) 2.69
1/26/2007 (100) 2.69
1/26/2007 (100) 2.6666
1/26/2007 (100) 2.6667
1/26/2007 100 2.59
1/26/2007 100 2.59
1/26/2007 100 2.6
1/26/2007 100 2.61
1/26/2007 (100) 2.62
1/26/2007 (100) 2.67
1/26/2007 (100) 2.68
1/29/2007 (100) 2.71
1/29/2007 (100) 2.71
1/29/2007 (100) 2.71
1/29/2007 (100) 2.73
1/29/2007 (100) 2.73
1/29/2007 (100) 2.73
1/29/2007 (100) 2.73
1/29/2007 (100) 2.73
1/29/2007 (100) 2.74
1/29/2007 (100) 2.74
1/29/2007 (100) 2.74
1/29/2007 (100) 2.78
1/29/2007 (100) 2.78
1/29/2007 (100) 2.78
1/29/2007 (100) 2.82
1/29/2007 (100) 2.82
1/29/2007 (100) 2.84
1/29/2007 (100) 2.85
1/29/2007 (100) 2.93
1/29/2007 7 2.88
1/29/2007 100 2.67
1/29/2007 100 2.73
1/29/2007 100 2.75
1/29/2007 100 2.75
1/29/2007 100 2.8
1/29/2007 100 2.8
1/29/2007 100 2.85
1/29/2007 100 2.85
1/29/2007 100 2.86
1/29/2007 15 2.69
1/29/2007 85 2.69
1/31/2007 (100) 2.8966
1/31/2007 400 2.8544
1/31/2007 (100) 2.84
1/31/2007 (100) 2.86
1/31/2007 (100) 2.87
1/31/2007 (100) 2.87
1/31/2007 (100) 2.88
1/31/2007 (100) 2.88
1/31/2007 (100) 2.88
1/31/2007 (100) 2.89
1/31/2007 (100) 2.9
1/31/2007 (100) 2.9
1/31/2007 (100) 2.9
1/31/2007 (100) 2.9
1/31/2007 (100) 2.92
1/31/2007 (100) 2.89
2/1/2007 (200) 2.88
2/1/2007 (100) 2.9025
2/1/2007 (100) 2.91
2/1/2007 (200) 2.87
2/1/2007 (100) 2.85
2/1/2007 (100) 2.85
2/1/2007 (100) 2.85
2/1/2007 (100) 2.85
2/1/2007 (100) 2.85
2/1/2007 (100) 2.85
2/1/2007 (100) 2.85
2/1/2007 (100) 2.85
2/1/2007 (100) 2.85
2/1/2007 (100) 2.85
2/1/2007 (100) 2.86
2/1/2007 (100) 2.87
2/1/2007 (100) 2.87
2/1/2007 (100) 2.87
2/1/2007 (100) 2.87
2/1/2007 (100) 2.88
2/1/2007 (100) 2.88
2/1/2007 (100) 2.88
2/1/2007 (100) 2.88
2/1/2007 (100) 2.88
2/1/2007 (100) 2.88
2/1/2007 (100) 2.89
2/1/2007 (100) 2.89
2/1/2007 (100) 2.89
2/1/2007 (100) 2.89
2/1/2007 (100) 2.89
2/1/2007 (100) 2.9
2/1/2007 (100) 2.9
2/1/2007 (100) 2.9
2/1/2007 (100) 2.9
2/1/2007 (100) 2.9
2/1/2007 (100) 2.91
2/1/2007 (100) 2.92
2/1/2007 (100) 2.93
2/1/2007 (100) 2.93
2/1/2007 (200) 2.88
2/1/2007 (100) 2.85
2/1/2007 (100) 2.85
2/1/2007 (100) 2.87
2/1/2007 (100) 2.89
2/1/2007 (100) 2.89
2/1/2007 (100) 2.9
2/1/2007 (100) 2.93
2/1/2007 (50) 2.89
2/1/2007 (50) 2.89
2/2/2007 (400) 2.9
2/2/2007 (200) 2.91
2/2/2007 (100) 2.9
2/2/2007 (100) 2.9
2/2/2007 (100) 2.9
2/2/2007 (100) 2.9
2/2/2007 (100) 2.9
2/2/2007 (100) 2.9
2/2/2007 (100) 2.9
2/2/2007 (100) 2.9
2/2/2007 (100) 2.9
2/2/2007 (100) 2.9
2/2/2007 (100) 2.9
2/2/2007 (100) 2.91
2/2/2007 (100) 2.91
2/2/2007 (100) 2.91
2/2/2007 (100) 2.93
2/2/2007 (100) 2.93
2/2/2007 (100) 2.95
2/2/2007 (100) 2.99
2/2/2007 (100) 3
2/2/2007 (100) 3
2/2/2007 (100) 3
2/2/2007 (90) 2.9
2/2/2007 (80) 2.9
2/2/2007 (100) 2.9
2/5/2007 (200) 2.81
2/5/2007 (200) 2.81
2/5/2007 (200) 2.81
2/5/2007 (800) 2.84
2/5/2007 (600) 2.81
2/5/2007 (300) 2.81
2/5/2007 (300) 2.82
2/5/2007 (300) 2.86
2/5/2007 (100) 2.8
2/5/2007 (100) 2.8
2/5/2007 (100) 2.81
2/5/2007 (100) 2.81
2/5/2007 (100) 2.81
2/5/2007 (100) 2.81
2/5/2007 (100) 2.82
2/5/2007 (100) 2.82
2/5/2007 (100) 2.82
2/5/2007 (100) 2.82
2/5/2007 (100) 2.84
2/5/2007 (100) 2.84
2/5/2007 (100) 2.85
2/5/2007 (100) 2.85
2/5/2007 (100) 2.85
2/5/2007 (100) 2.85
2/5/2007 (100) 2.86
2/5/2007 (100) 2.86
2/5/2007 (100) 2.86
2/5/2007 (100) 2.88
2/5/2007 (100) 2.89
2/5/2007 (100) 2.91
2/5/2007 (100) 2.92
2/5/2007 (100) 2.92
2/5/2007 (100) 2.84
2/6/2007 100 2.7933
2/6/2007 (3,900) 2.7668
2/6/2007 (100) 2.69
2/6/2007 (200) 2.7
2/6/2007 (200) 2.7
2/6/2007 (200) 2.7
2/6/2007 (200) 2.7
2/6/2007 (200) 2.7
2/6/2007 (200) 2.73
2/6/2007 (200) 2.74
2/6/2007 (200) 2.74
2/6/2007 (200) 2.74
2/6/2007 (200) 2.74
2/6/2007 (200) 2.75
2/6/2007 (200) 2.75
2/6/2007 (200) 2.75
2/6/2007 (200) 2.77
2/6/2007 (200) 2.78
2/6/2007 (200) 2.78
2/6/2007 (200) 2.79
2/6/2007 (200) 2.79
2/6/2007 (200) 2.8
2/6/2007 (200) 2.8
2/6/2007 (200) 2.8
2/6/2007 (100) 2.7
2/6/2007 (100) 2.71
2/6/2007 (100) 2.71
2/6/2007 (100) 2.73
2/6/2007 (100) 2.73
2/6/2007 (100) 2.73
2/6/2007 (100) 2.73
2/6/2007 (100) 2.73
2/6/2007 (100) 2.73
2/6/2007 (100) 2.74
2/6/2007 (100) 2.74
2/6/2007 (100) 2.74
2/6/2007 (100) 2.74
2/6/2007 (100) 2.74
2/6/2007 (100) 2.74
2/6/2007 (100) 2.75
2/6/2007 (100) 2.75
2/6/2007 (100) 2.75
2/6/2007 (100) 2.75
2/6/2007 (100) 2.76
2/6/2007 (100) 2.76
2/6/2007 (100) 2.76
2/6/2007 (100) 2.77
2/6/2007 (100) 2.77
2/6/2007 (100) 2.78
2/6/2007 (100) 2.78
2/6/2007 (100) 2.78
2/6/2007 (100) 2.79
2/6/2007 (100) 2.79
2/6/2007 (100) 2.79
2/6/2007 (100) 2.79
2/6/2007 (100) 2.79
2/6/2007 (100) 2.79
2/6/2007 (100) 2.79
2/6/2007 (100) 2.8
2/6/2007 (100) 2.8
2/6/2007 (100) 2.8
2/6/2007 (100) 2.8
2/6/2007 (100) 2.8
2/6/2007 (100) 2.85
2/6/2007 (100) 2.85
2/6/2007 (200) 2.7
2/6/2007 (200) 2.7
2/6/2007 (200) 2.73
2/6/2007 (200) 2.74
2/6/2007 (200) 2.77
2/6/2007 (200) 2.79
2/6/2007 (200) 2.79
2/6/2007 (200) 2.8
2/6/2007 (200) 2.8
2/6/2007 (100) 2.71
2/6/2007 (100) 2.73
2/6/2007 (100) 2.73
2/6/2007 (100) 2.73
2/6/2007 (100) 2.73
2/6/2007 (100) 2.73
2/6/2007 (100) 2.74
2/6/2007 (100) 2.74
2/6/2007 (100) 2.74
2/6/2007 (100) 2.74
2/6/2007 (100) 2.75
2/6/2007 (100) 2.75
2/6/2007 (100) 2.75
2/6/2007 (100) 2.75
2/6/2007 (100) 2.75
2/6/2007 (100) 2.75
2/6/2007 (100) 2.75
2/6/2007 (100) 2.77
2/6/2007 (100) 2.77
2/6/2007 (100) 2.79
2/6/2007 (100) 2.79
2/6/2007 (100) 2.79
2/6/2007 (100) 2.79
2/6/2007 (100) 2.8
2/6/2007 (100) 2.8
2/6/2007 (100) 2.8
2/6/2007 (9) 2.77
2/7/2007 (2,800) 2.7907
2/7/2007 (600) 2.78
2/7/2007 (500) 2.78
2/7/2007 (300) 2.78
2/7/2007 (100) 2.77
2/7/2007 (100) 2.77
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.79
2/7/2007 (100) 2.8
2/7/2007 (100) 2.8
2/7/2007 (100) 2.8
2/7/2007 (100) 2.8
2/7/2007 (100) 2.8
2/7/2007 (100) 2.8
2/7/2007 (100) 2.8
2/7/2007 (100) 2.8
2/7/2007 (100) 2.8
2/7/2007 (100) 2.8
2/7/2007 (100) 2.8
2/7/2007 (100) 2.8
2/7/2007 (100) 2.83
2/7/2007 (100) 2.83
2/7/2007 (94) 2.79
2/7/2007 (94) 2.79
2/7/2007 (44) 2.8
2/7/2007 (6) 2.77
2/7/2007 (100) 2.78
2/7/2007 (100) 2.78
2/7/2007 (100) 2.79
2/8/2007 (200) 2.7886
2/8/2007 (100) 2.77
2/8/2007 (100) 2.77
2/8/2007 (100) 2.77
2/8/2007 (100) 2.77
2/8/2007 (100) 2.79
2/8/2007 (100) 2.79
2/8/2007 (100) 2.79
2/8/2007 (100) 2.8
2/8/2007 (100) 2.8
2/8/2007 (100) 2.8
2/8/2007 (100) 2.8
2/8/2007 (100) 2.8
2/8/2007 (100) 2.8
2/8/2007 (100) 2.8
2/8/2007 (95) 2.8
2/8/2007 (11) 2.8
2/8/2007 (100) 2.79
2/9/2007 (200) 2.76
2/9/2007 (200) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.76
2/9/2007 (100) 2.77
2/9/2007 (100) 2.81
2/9/2007 (100) 2.81
2/9/2007 (100) 2.81
2/9/2007 (100) 2.81
2/9/2007 (100) 2.81
2/9/2007 (100) 2.81
2/9/2007 (79) 2.76
2/12/2007 (200) 2.8
2/12/2007 (100) 2.72
2/12/2007 (100) 2.72
2/12/2007 (100) 2.73
2/12/2007 (100) 2.73
2/12/2007 (100) 2.73
2/12/2007 (100) 2.73
2/12/2007 (100) 2.74
2/12/2007 (100) 2.75
2/12/2007 (100) 2.75
2/12/2007 (100) 2.75
2/12/2007 (100) 2.75
2/12/2007 (100) 2.75
2/12/2007 (100) 2.75
2/12/2007 (100) 2.76
2/12/2007 (100) 2.76
2/12/2007 (100) 2.76
2/12/2007 (100) 2.77
2/12/2007 (100) 2.77
2/12/2007 (100) 2.79
2/12/2007 (100) 2.79
2/12/2007 (100) 2.8
2/12/2007 (100) 2.8
2/12/2007 (100) 2.8
2/12/2007 (100) 2.8
2/12/2007 (100) 2.8
2/12/2007 (100) 2.8
2/12/2007 (100) 2.8
2/12/2007 (100) 2.8
2/12/2007 (100) 2.8
2/12/2007 (99) 2.73
2/12/2007 (27) 2.73
2/12/2007 (1) 2.73
2/13/2007 5 2.75
2/13/2007 95 2.75
2/13/2007 100 2.7
2/13/2007 100 2.7
2/13/2007 100 2.71
2/13/2007 100 2.71
2/13/2007 100 2.71
2/13/2007 100 2.75
2/13/2007 100 2.76
2/13/2007 100 2.76
2/13/2007 600 2.75
2/13/2007 700 2.7
2/13/2007 100 2.7
2/14/2007 133 2.4034
2/14/2007 (200) 2.07
2/14/2007 (200) 2.2
2/14/2007 (200) 2.25
2/14/2007 (200) 2.3
2/14/2007 (200) 2.3
2/14/2007 (200) 2.33
2/14/2007 (300) 2.36
2/14/2007 (200) 2.32
2/14/2007 (200) 2.32
2/14/2007 (200) 2.33
2/14/2007 (200) 2.33
2/14/2007 (100) 2.04
2/14/2007 (100) 2.07
2/14/2007 (100) 2.12
2/14/2007 (100) 2.13
2/14/2007 (100) 2.14
2/14/2007 (100) 2.17
2/14/2007 (100) 2.2
2/14/2007 (100) 2.2
2/14/2007 (100) 2.21
2/14/2007 (100) 2.25
2/14/2007 (100) 2.28
2/14/2007 (100) 2.34
2/14/2007 (100) 2.34
2/14/2007 (100) 2.34
2/14/2007 (100) 2.34
2/14/2007 (100) 2.35
2/14/2007 (100) 2.35
2/14/2007 (100) 2.36
2/14/2007 (100) 2.36
2/14/2007 (100) 2.36
2/14/2007 (100) 2.36
2/14/2007 (100) 2.36
2/14/2007 (100) 2.36
2/14/2007 (100) 2.36
2/14/2007 (100) 2.36
2/14/2007 (100) 2.37
2/14/2007 (100) 2.38
2/14/2007 (100) 2.4
2/14/2007 (100) 2.31
2/14/2007 (100) 2.31
2/14/2007 (100) 2.34
2/14/2007 (100) 2.35
2/14/2007 (100) 2.35
2/14/2007 (100) 2.36
2/14/2007 (100) 2.36
2/14/2007 19 2.34
2/14/2007 20 2.35
2/14/2007 100 2.32
2/14/2007 100 2.32
2/14/2007 100 2.32
2/14/2007 100 2.32
2/14/2007 100 2.33
2/14/2007 100 2.34
2/14/2007 100 2.34
2/14/2007 100 2.34
2/14/2007 100 2.34
2/14/2007 100 2.34
2/14/2007 100 2.34
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 200 2.32
2/14/2007 200 2.32
2/14/2007 200 2.32
2/14/2007 200 2.33
2/14/2007 200 2.34
2/14/2007 200 2.34
2/14/2007 200 2.35
2/14/2007 200 2.35
2/14/2007 200 2.35
2/14/2007 210 2.35
2/14/2007 300 2.33
2/14/2007 300 2.35
2/14/2007 300 2.35
2/14/2007 300 2.35
2/14/2007 300 2.35
2/14/2007 305 2.34
2/14/2007 400 2.32
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 490 2.35
2/14/2007 495 2.34
2/14/2007 500 2.31
2/14/2007 500 2.32
2/14/2007 500 2.35
2/14/2007 500 2.35
2/14/2007 500 2.35
2/14/2007 500 2.35
2/14/2007 500 2.35
2/14/2007 600 2.32
2/14/2007 600 2.35
2/14/2007 600 2.35
2/14/2007 700 2.35
2/14/2007 700 2.35
2/14/2007 800 2.35
2/14/2007 1,100 2.34
2/14/2007 1,100 2.34
2/14/2007 1,100 2.34
2/14/2007 1,100 2.34
2/14/2007 1,200 2.35
2/14/2007 1,200 2.35
2/14/2007 1,200 2.35
2/14/2007 1,300 2.35
2/14/2007 1,574 2.35
2/14/2007 1,600 2.35
2/14/2007 1,800 2.35
2/14/2007 2,000 2.35
2/14/2007 2,000 2.35
2/14/2007 2,000 2.35
2/14/2007 2,100 2.35
2/14/2007 2,500 2.35
2/14/2007 2,700 2.35
2/14/2007 2,700 2.35
2/14/2007 2,700 2.35
2/14/2007 2,990 2.35
2/14/2007 3,100 2.35
2/14/2007 3,180 2.35
2/14/2007 3,200 2.35
2/14/2007 3,200 2.35
2/14/2007 3,200 2.35
2/14/2007 3,420 2.35
2/14/2007 9,626 2.31
2/14/2007 13,650 2.34
2/14/2007 16,416 2.35
2/14/2007 20,600 2.34
2/14/2007 21,800 2.35
2/14/2007 22,405 2.34
2/14/2007 23,900 2.34
2/14/2007 100 2.15
2/14/2007 100 2.15
2/14/2007 100 2.16
2/14/2007 100 2.16
2/14/2007 100 2.16
2/14/2007 100 2.16
2/14/2007 100 2.17
2/14/2007 100 2.17
2/14/2007 100 2.17
2/14/2007 100 2.17
2/14/2007 100 2.17
2/14/2007 100 2.17
2/14/2007 100 2.17
2/14/2007 100 2.18
2/14/2007 100 2.2
2/14/2007 100 2.25
2/14/2007 100 2.25
2/14/2007 100 2.25
2/14/2007 100 2.25
2/14/2007 100 2.25
2/14/2007 100 2.25
2/14/2007 100 2.25
2/14/2007 100 2.25
2/14/2007 100 2.26
2/14/2007 100 2.27
2/14/2007 100 2.27
2/14/2007 100 2.28
2/14/2007 100 2.28
2/14/2007 100 2.28
2/14/2007 100 2.28
2/14/2007 100 2.28
2/14/2007 100 2.28
2/14/2007 100 2.28
2/14/2007 100 2.28
2/14/2007 100 2.28
2/14/2007 100 2.28
2/14/2007 100 2.31
2/14/2007 100 2.31
2/14/2007 100 2.31
2/14/2007 100 2.31
2/14/2007 100 2.31
2/14/2007 100 2.31
2/14/2007 100 2.31
2/14/2007 100 2.31
2/14/2007 100 2.31
2/14/2007 100 2.32
2/14/2007 100 2.32
2/14/2007 100 2.32
2/14/2007 100 2.32
2/14/2007 100 2.32
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.33
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.35
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.37
2/14/2007 155 2.13
2/14/2007 155 2.13
2/14/2007 200 2.15
2/14/2007 200 2.15
2/14/2007 200 2.15
2/14/2007 200 2.15
2/14/2007 200 2.15
2/14/2007 200 2.18
2/14/2007 200 2.18
2/14/2007 200 2.28
2/14/2007 200 2.28
2/14/2007 200 2.28
2/14/2007 200 2.28
2/14/2007 200 2.29
2/14/2007 200 2.31
2/14/2007 200 2.31
2/14/2007 200 2.31
2/14/2007 200 2.31
2/14/2007 200 2.32
2/14/2007 200 2.32
2/14/2007 300 2.2
2/14/2007 300 2.2
2/14/2007 300 2.2
2/14/2007 300 2.2
2/14/2007 300 2.2
2/14/2007 300 2.2
2/14/2007 300 2.2
2/14/2007 300 2.2
2/14/2007 300 2.28
2/14/2007 300 2.28
2/14/2007 300 2.28
2/14/2007 300 2.28
2/14/2007 300 2.31
2/14/2007 300 2.31
2/14/2007 300 2.35
2/14/2007 300 2.35
2/14/2007 300 2.35
2/14/2007 300 2.35
2/14/2007 375 2.29
2/14/2007 400 2.25
2/14/2007 400 2.28
2/14/2007 400 2.28
2/14/2007 400 2.28
2/14/2007 400 2.31
2/14/2007 400 2.31
2/14/2007 400 2.31
2/14/2007 400 2.32
2/14/2007 400 2.33
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.35
2/14/2007 400 2.37
2/14/2007 402 2.35
2/14/2007 451 2.35
2/14/2007 451 2.35
2/14/2007 500 2.15
2/14/2007 500 2.15
2/14/2007 500 2.15
2/14/2007 500 2.18
2/14/2007 500 2.25
2/14/2007 500 2.31
2/14/2007 500 2.35
2/14/2007 500 2.35
2/14/2007 500 2.35
2/14/2007 500 2.35
2/14/2007 500 2.35
2/14/2007 500 2.35
2/14/2007 500 2.35
2/14/2007 502 2.35
2/14/2007 600 2.2
2/14/2007 600 2.2
2/14/2007 600 2.2
2/14/2007 600 2.2
2/14/2007 600 2.2
2/14/2007 600 2.2
2/14/2007 600 2.31
2/14/2007 600 2.31
2/14/2007 600 2.35
2/14/2007 600 2.35
2/14/2007 600 2.35
2/14/2007 600 2.35
2/14/2007 700 2.15
2/14/2007 700 2.17
2/14/2007 700 2.18
2/14/2007 700 2.25
2/14/2007 700 2.31
2/14/2007 800 2.25
2/14/2007 800 2.31
2/14/2007 800 2.31
2/14/2007 800 2.31
2/14/2007 800 2.31
2/14/2007 800 2.31
2/14/2007 800 2.31
2/14/2007 800 2.31
2/14/2007 800 2.31
2/14/2007 800 2.31
2/14/2007 800 2.31
2/14/2007 802 2.35
2/14/2007 802 2.35
2/14/2007 802 2.35
2/14/2007 802 2.35
2/14/2007 900 2.2
2/14/2007 900 2.2
2/14/2007 900 2.31
2/14/2007 900 2.31
2/14/2007 900 2.31
2/14/2007 900 2.31
2/14/2007 900 2.31
2/14/2007 900 2.31
2/14/2007 900 2.31
2/14/2007 900 2.31
2/14/2007 900 2.31
2/14/2007 900 2.31
2/14/2007 900 2.31
2/14/2007 1,000 2.15
2/14/2007 1,000 2.17
2/14/2007 1,000 2.31
2/14/2007 1,000 2.31
2/14/2007 1,000 2.31
2/14/2007 1,000 2.31
2/14/2007 1,000 2.31
2/14/2007 1,000 2.31
2/14/2007 1,000 2.31
2/14/2007 1,000 2.31
2/14/2007 1,000 2.31
2/14/2007 1,100 2.31
2/14/2007 1,100 2.31
2/14/2007 1,100 2.31
2/14/2007 1,200 2.2
2/14/2007 1,200 2.2
2/14/2007 1,200 2.2
2/14/2007 1,200 2.25
2/14/2007 1,200 2.25
2/14/2007 1,500 2.15
2/14/2007 1,500 2.15
2/14/2007 1,500 2.15
2/14/2007 1,500 2.15
2/14/2007 1,500 2.15
2/14/2007 1,500 2.15
2/14/2007 1,500 2.18
2/14/2007 1,500 2.18
2/14/2007 1,500 2.2
2/14/2007 1,500 2.2
2/14/2007 1,600 2.35
2/14/2007 1,700 2.31
2/14/2007 1,800 2.18
2/14/2007 1,800 2.25
2/14/2007 1,800 2.31
2/14/2007 1,800 2.31
2/14/2007 1,800 2.31
2/14/2007 1,996 2.18
2/14/2007 2,000 2.15
2/14/2007 2,000 2.31
2/14/2007 2,000 2.31
2/14/2007 2,000 2.31
2/14/2007 2,100 2.18
2/14/2007 2,100 2.25
2/14/2007 2,200 2.25
2/14/2007 2,200 2.25
2/14/2007 2,300 2.25
2/14/2007 2,484 2.35
2/14/2007 2,700 2.35
2/14/2007 3,000 2.15
2/14/2007 3,690 2.31
2/14/2007 4,000 2.15
2/14/2007 4,000 2.15
2/14/2007 4,400 2.25
2/14/2007 4,400 2.25
2/14/2007 5,537 2.35
2/14/2007 6,600 2.32
2/14/2007 9,425 2.17
2/14/2007 11,500 2.18
2/14/2007 24,600 2.32
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.36
2/14/2007 100 2.37
2/14/2007 100 2.37
2/14/2007 100 2.37
2/14/2007 100 2.37
2/14/2007 100 2.37
2/14/2007 100 2.37
2/14/2007 200 2.36
2/14/2007 200 2.36
2/14/2007 200 2.36
2/14/2007 200 2.36
2/14/2007 200 2.36
2/14/2007 200 2.36
2/14/2007 300 2.37
2/14/2007 300 2.37
2/14/2007 400 2.35
2/14/2007 500 2.37
2/14/2007 500 2.37
2/14/2007 600 2.35
2/14/2007 600 2.37
2/14/2007 1,000 2.35
2/14/2007 1,000 2.35
2/14/2007 1,000 2.35
2/14/2007 1,000 2.35
2/14/2007 1,000 2.35
2/14/2007 1,000 2.35
2/14/2007 1,000 2.35
2/14/2007 1,000 2.35
2/14/2007 1,100 2.37
2/14/2007 1,100 2.37
2/14/2007 2,000 2.35
2/14/2007 2,000 2.35
2/14/2007 2,000 2.35
2/15/2007 100 2.43
2/15/2007 100 2.44
2/15/2007 100 2.45
2/15/2007 100 2.45
2/15/2007 100 2.45
2/15/2007 100 2.46
2/15/2007 100 2.46
2/15/2007 100 2.46
2/15/2007 100 2.48
2/15/2007 100 2.49
2/15/2007 100 2.5
2/15/2007 100 2.5
2/15/2007 100 2.5
2/15/2007 200 2.47
2/15/2007 200 2.47
2/15/2007 300 2.43
2/15/2007 300 2.44
2/15/2007 300 2.44
2/15/2007 300 2.45
2/15/2007 300 2.47
2/15/2007 300 2.47
2/15/2007 300 2.48
2/15/2007 300 2.48
2/15/2007 400 2.46
2/15/2007 500 2.49
2/15/2007 600 2.46
2/15/2007 600 2.47
2/15/2007 600 2.47
2/15/2007 600 2.5
2/15/2007 700 2.48
2/15/2007 700 2.48
2/15/2007 700 2.49
2/15/2007 800 2.46
2/15/2007 1,000 2.5
2/15/2007 1,700 2.44
2/15/2007 1,700 2.44
2/15/2007 2,200 2.43
2/15/2007 2,400 2.45
2/15/2007 4,500 2.45
2/15/2007 4,900 2.44
2/15/2007 5,000 2.47
2/15/2007 5,000 2.47
2/15/2007 5,000 2.5
2/15/2007 9,900 2.48
2/15/2007 11,000 2.45
2/15/2007 (1,500) 2.42
2/15/2007 (1,031) 2.39
2/15/2007 (1,000) 2.39
2/15/2007 (900) 2.39
2/15/2007 (700) 2.39
2/15/2007 (500) 2.39
2/15/2007 (500) 2.42
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.39
2/15/2007 (300) 2.4
2/15/2007 (300) 2.4
2/15/2007 (300) 2.4
2/15/2007 (300) 2.4
2/15/2007 (300) 2.4
2/15/2007 (300) 2.4
2/15/2007 (300) 2.4
2/15/2007 (300) 2.4
2/15/2007 (300) 2.4
2/15/2007 (300) 2.42
2/15/2007 (200) 2.39
2/15/2007 (200) 2.39
2/15/2007 (200) 2.39
2/15/2007 (200) 2.39
2/15/2007 (200) 2.39
2/15/2007 (200) 2.4
2/15/2007 (200) 2.4
2/15/2007 (200) 2.4
2/15/2007 (200) 2.42
2/15/2007 (100) 2.39
2/15/2007 (100) 2.39
2/15/2007 (100) 2.39
2/15/2007 (100) 2.39
2/15/2007 (100) 2.39
2/15/2007 (100) 2.39
2/15/2007 (100) 2.39
2/15/2007 (100) 2.39
2/15/2007 (100) 2.39
2/15/2007 (100) 2.39
2/15/2007 (100) 2.39
2/15/2007 (100) 2.39
2/15/2007 (100) 2.4
2/15/2007 (100) 2.4
2/15/2007 (100) 2.4
2/15/2007 (100) 2.4
2/15/2007 (100) 2.4
2/15/2007 (100) 2.42
2/15/2007 23 2.41
2/15/2007 100 2.39
2/15/2007 100 2.39
2/15/2007 100 2.39
2/15/2007 100 2.39
2/15/2007 100 2.4
2/15/2007 100 2.4
2/15/2007 100 2.4
2/15/2007 100 2.4
2/15/2007 100 2.4
2/15/2007 100 2.4
2/15/2007 100 2.41
2/15/2007 100 2.41
2/15/2007 100 2.41
2/15/2007 100 2.41
2/15/2007 100 2.41
2/15/2007 100 2.41
2/15/2007 100 2.41
2/15/2007 100 2.41
2/15/2007 100 2.41
2/15/2007 100 2.41
2/15/2007 100 2.41
2/15/2007 100 2.41
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.42
2/15/2007 100 2.43
2/15/2007 100 2.43
2/15/2007 100 2.43
2/15/2007 100 2.43
2/15/2007 100 2.43
2/15/2007 100 2.43
2/15/2007 100 2.43
2/15/2007 100 2.43
2/15/2007 100 2.44
2/15/2007 100 2.44
2/15/2007 100 2.45
2/15/2007 100 2.45
2/15/2007 100 2.45
2/15/2007 100 2.45
2/15/2007 200 2.41
2/15/2007 200 2.42
2/15/2007 200 2.42
2/15/2007 200 2.42
2/15/2007 200 2.45
2/15/2007 300 2.38
2/15/2007 300 2.4
2/15/2007 300 2.4
2/15/2007 300 2.4
2/15/2007 300 2.4
2/15/2007 300 2.4
2/15/2007 300 2.4
2/15/2007 300 2.41
2/15/2007 300 2.41
2/15/2007 300 2.41
2/15/2007 300 2.41
2/15/2007 300 2.41
2/15/2007 300 2.41
2/15/2007 300 2.42
2/15/2007 300 2.42
2/15/2007 300 2.42
2/15/2007 300 2.44
2/15/2007 300 2.45
2/15/2007 370 2.39
2/15/2007 400 2.4
2/15/2007 400 2.42
2/15/2007 400 2.42
2/15/2007 400 2.42
2/15/2007 500 2.4
2/15/2007 500 2.4
2/15/2007 500 2.4
2/15/2007 500 2.41
2/15/2007 500 2.41
2/15/2007 500 2.41
2/15/2007 500 2.41
2/15/2007 500 2.41
2/15/2007 500 2.44
2/15/2007 500 2.44
2/15/2007 500 2.44
2/15/2007 500 2.44
2/15/2007 500 2.44
2/15/2007 500 2.44
2/15/2007 500 2.44
2/15/2007 500 2.44
2/15/2007 500 2.44
2/15/2007 500 2.44
2/15/2007 500 2.45
2/15/2007 500 2.45
2/15/2007 500 2.45
2/15/2007 500 2.45
2/15/2007 500 2.45
2/15/2007 600 2.4
2/15/2007 600 2.41
2/15/2007 600 2.44
2/15/2007 600 2.45
2/15/2007 700 2.4
2/15/2007 700 2.4
2/15/2007 700 2.4
2/15/2007 700 2.4
2/15/2007 700 2.4
2/15/2007 700 2.4
2/15/2007 700 2.4
2/15/2007 700 2.4
2/15/2007 700 2.4
2/15/2007 800 2.39
2/15/2007 800 2.41
2/15/2007 800 2.41
2/15/2007 800 2.44
2/15/2007 800 2.45
2/15/2007 800 2.45
2/15/2007 900 2.42
2/15/2007 1,000 2.4
2/15/2007 1,000 2.44
2/15/2007 1,000 2.44
2/15/2007 1,100 2.4
2/15/2007 1,100 2.4
2/15/2007 1,100 2.4
2/15/2007 1,100 2.4
2/15/2007 1,100 2.45
2/15/2007 1,100 2.45
2/15/2007 1,200 2.44
2/15/2007 1,300 2.4
2/15/2007 1,600 2.45
2/15/2007 1,600 2.45
2/15/2007 2,000 2.45
2/15/2007 2,000 2.45
2/15/2007 2,200 2.44
2/15/2007 2,300 2.39
2/15/2007 2,500 2.43
2/15/2007 3,000 2.45
2/15/2007 4,400 2.43
2/15/2007 4,707 2.36
2/15/2007 5,000 2.44
2/15/2007 5,300 2.41
2/15/2007 7,000 2.44
2/15/2007 9,700 2.41
2/15/2007 19,200 2.41
2/15/2007 100 2.25
2/15/2007 100 2.25
2/15/2007 453 2.25
2/15/2007 4,347 2.25

Note:  All such transactions were effected by Millenco.

-----END PRIVACY-ENHANCED MESSAGE-----